Behçet disease (BD) is a chronic relapsing systemic vasculitic disorder affecting the arteries, veins, and vessels of any size. Vascular lesions in BD usually represent an occlusive nature suggesting a hypercoagulable/prothrombotic state. Coronary arteries are rarely involved in BD. In this report, a 27-year-old male patient in whom myocardial infarction developed secondary to coronary arterial thrombosis together with deep venous thrombosis was presented. This is a review of the pathologic hemostasis and the prothrombotic state of BD.
Sakane T, Takeno M, Suzuki N, et al.Behçet’s disease. N Engl J Med1999;341:1284.
2.
Behçet H. Über rezidiverende aphthöse durch ein virus verursachte Geschwüre am Mund, am Auge, und an den Genitalien. Dermatol Wochenzchr 1937;105:1152.
3.
International Study Group for Behcet’s disease. Criteria for diagnosis of Behcet’s disease. Lancet1990;335:1078.
4.
Drobinski G, Wechsler B, Pavie A, et al.Emergency percutaneous coronary dilatation for acute myocardial infarction in Behcet’s disease. Eur Heart J1987;8:1133.
5.
Lakhanpal S, Tani K, Lie JT, et al.Pathologic features of Behçet’s syndrome: A review of Japanase autopsy registry data. Hum Pathol1985;16:790.
6.
Siepmann M, Kirch W. Coronary anomaly in Behçet’s syndrome. Rheumatol Int1997;17:39.
7.
Hutchison SJ, Belch JJ. Behçet’s syndrome presenting as myocardial infarction with impaired blood fibrinolysis. Br Heart J1984;52:686.
8.
Schiff S, Moffatt R, Mandel WJ, et al.Acute myocardial infarction and recurrent ventricular arrhythmias in Behcet’s syndrome. Am Heart J1982;103:438.
9.
Bowles CA, Nelson AM, Hammill SC, et al.Cardiac involvement in Behçet’s disease. Arthritis Rheum1985;28:345.
10.
Ioakimidis D, Georganas C, Panagoulis C, et al.A case of Adamantiadis-Behçet’s syndrome presenting as myocardial infarction. Clin Exp Rheumatol1993;11:183.
11.
Putini RL, Natale E, Di Marcotullio G, et al.Acute coronary syndrome and late stent failure in a patient with Behcet’s syndrome. Ital Heart J2003;4:281.
12.
Hattori S, Kawana S. Behcet’s syndrome associated with acute myocardial infarction. J Nippon Med Sch2003;70:49.
13.
Tezcan H, Yavuz S, Fak AS, et al.Coronary stent implantation in Behcet’s disease. Clin Exp Rheumatol2002;20:704.
14.
Gullu IH, Benekli M, Muderrisoglu H, et al.Silent myocardial ischemia in Behcet’s disease. J Rheumatol1996;23:323.
15.
Koc Y, Gullu I, Akpek G, et al.Vascular involvement in Behçet’s disease. J Rheumatol1992;19:402.
16.
Koşar A, Haznedaroğlu IC, Büyükaşık Y, et al.Activated protein C resistance in Behçet’s disease. Rheumatol Int1998;17:249.
17.
Gül A, Aslantas AB, Tekinay T, et al.Procoagulant mutations and venous thrombosis in Behçet’s disease. Rheumatology1999;38:1298.
18.
Haznedaroğlu IC, Ozcebe O, Çelik I, et al.Haemostatic markers of procoagulant inbalance in Behçet’s disease. Eur J Haematol1996;57:107.
19.
Haznedaroğlu IC, Özcebe O, Özdemir O, et al.Impaired haemostatic kinetics and endothelial function in Behçet’s disease. J Intern Med1996;240:181.
20.
Haznedaroğlu IC, Çelik I, Büyükaşık Y, et al.Haemostasis, thrombosis, and endothelium in Behçet’s disease. Acta Haematol1998;99:296.
21.
Ozturk MA, Ozbalkan Z, Onat AM, et al.Decreased protein Z concentrations complicating the hypercoagulable state of Behcet’s disease. Clin Appl Thromb Hemost2003;9:259.
22.
Ertenli I, Kiraz S, Celik IC, et al.Changes in the concentration and distribution of tissue factor pathway inhibitor in Behcet’s disease and systemic lupus erythematosus: Effect on the prethrombotic state. Ann Rheum Dis2001;60:1149.
23.
Ozoran K, Dugun H, Gurler A, et al.Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet’s disease. Scand J Rheumatol1995;24:376.
24.
Haznedaroğlu IC, Özdemir O, Özcebe O, et al.Circulating thrombomodulin as a clue of endothelial damage in Behçet’s disease. Thromb Haemost1996;75:974.
25.
Özcebe O, Haznedaroğlu IC, Özdemir O, et al.Soluble thrombomodulin and fibrinolysis in Behçet’s disease. Med Principles Pract1996;5:146.
26.
Haznedaroğlu, Karaaslan Y, Büyükaşık Y, et al.Selectin adhesion molecule in Behçet’s disease. Ann Rheum Dis2000;59:61.
27.
Haznedaroğlu IC, Dündar SV, Kirazlı Ş. Eicosanoids in the prethrombotic state of Behçet’s disease. Thromb Res1995;80:445.
28.
Kiraz S, Ertenli I, Ozturk MA, et al.Pathological haemostasis and “prothrombotic state” in Behcet’s disease. Thromb Res2002;105:125.
29.
O’Duffy JD. Vasculitis in Behçet’s disease. Rheum Dis Clin North Am1990;16:423.
30.
Barnes CG, Yazici H. Behçet’s syndrome. Rheumatology1999;38:1171.
31.
Zouboulis CC, Orfanos CE. Treatment of Adamantiades-Behçet Disease with systemic interferon alfa. Arch Dermatol1998;134:1010.
32.
Çalgüneri M, Öztürk MA, Ertenli I, et al.Effects of interferon alpha treatment on the clinical course of refractory Behçet’s disease: An open study. Ann Rheum Dis2003;62:492.